INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-17-00789

Residual “inter-clip” regurgitation due to a partial detachment, treated with AMPLATZER Vascular Plug II implantation

Leonardo Danduch*, MD; Xavier Millan, MD; Chi-Hion Li, MD; Dabit Arzamendi, MD, PhD

With proven safety and feasibility, percutaneous edge-to-edge mitral valve repair with the MitraClip System (Abbott Vascular, Santa Clara, CA, USA) is currently an option for patients with severe mitral regurgitation (MR) and at high surgical risk1. In about half of patients, more than one clip is needed to achieve a significant reduction of MR and, in up to 12.3% of patients, a regurgitant jet persists between or around the clips1. Implantation of additional clips to treat “inter-clip” regurgitation is not always feasible and, frequently, MR is left untreated, which is associated with poor clinical outcomes during follow-up1,2. Some reports of residual jet closure with the AMPLATZER™ Vascular Plug II (AVP II) device (St. Jude Medical, St. Paul, MN, USA) have shown reasonable results3,4. Herein, we present a case with partial detachment treated with this occluder.

A 61-year-old man, with cardiovascular risk factors (active smoker and type 2 diabetes), was admitted in 2015 with an inferior STEMI undergoing primary PCI. After the procedure, he developed heart failure; inferolateral akinesia was shown on echocardiography, with LVEF 41% and severe functional mitral regurgitation with tenting of the posterior mitral leaflet. The EuroSCORE II estimated risk of operative mortality was 5%. After discussion in the Heart Team, a decision was made to proceed with percutaneous treatment. Mitral valve reparation was performed with implantation of two MitraClip devices in A2-P2 position, with significant improvement of mitral regurgitation. Two years later, the patient was readmitted for heart failure despite optimal medical therapy. Transoesophageal echocardiography revealed reduction of the ejection fraction (LVEF 33%) and a detachment of the posterior leaflet of the medial clip, causing severe mitral regurgitation (Panel A-Panel C, Moving image 1, Moving image 2). We proceeded to implant a third MitraClip device in a medial position (Panel D) but severe mitral regurgitation persisted through the orifice between the central clip (detached) and the posterior leaflet (Panel E, Panel F, Moving image 3, Moving image 4). Due to the impossibility of placing another clip in this position, we proceeded to implant an AVP II 12 mm occluder device (Moving image 5), achieving a significant reduction of mitral regurgitation without significant increase of transmitral gradient (Panel G, Panel H, Moving image 6, Moving image 7). The patient could be discharged seven days after the procedure and, at 30 days of follow-up, he remains in NYHA functional Class II, without new admissions.

Conflict of interest statement

D. Arzamendi and C-H. Li are proctors for Abbott Vascular. The other authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Severe mitral regurgitation on transoesophageal echocardiography with colour Doppler.

Moving image 2. Severe mitral regurgitation on transoesophageal echocardiography 3D view.

Moving image 3. Persistence of severe mitral regurgitation after the third clip implantation.

Moving image 4. 3D view showing the regurgitant orifice between the central clip (detached) and the posterior leaflet.

Moving image 5. AVP II 12 mm occluder device deployment.

Moving image 6. Colour Doppler revealing significant reduction of mitral regurgitation.

Moving image 7. 3D view showing occlusion of the orifice.

To read the full content of this article, please download the PDF.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Severe mitral regurgitation on transoesophageal echocardiography with colour Doppler.

Moving image 2. Severe mitral regurgitation on transoesophageal echocardiography 3D view.

Moving image 3. Persistence of severe mitral regurgitation after the third clip implantation.

Moving image 4. 3D view showing the regurgitant orifice between the central clip (detached) and the posterior leaflet.

Moving image 5. AVP II 12 mm occluder device deployment.

Moving image 6. Colour Doppler revealing significant reduction of mitral regurgitation.

Moving image 7. 3D view showing occlusion of the orifice.

Volume 13 Number 15
Feb 2, 2018
Volume 13 Number 15
View full issue


Key metrics

Suggested by Cory

Clinical research

10.4244/EIJ-D-18-01148 Aug 9, 2019
Transcatheter therapy for residual mitral regurgitation after MitraClip therapy
Niikura H et al
free

10.4244/EIJV15I6A87 Aug 9, 2019
Patching residual leaks following a MitraClip procedure
Kar S and Sharma R
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-16-00943 Oct 20, 2017
Transcatheter mitral annuloplasty to treat residual mitral regurgitation after MitraClip implantation
Brüstle K et al
free

Clinical research

10.4244/EIJ-D-20-01008 Apr 20, 2021
Clinical impact of intervention strategies after failed transcatheter mitral valve repair
Alessandrini H et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-01064 Feb 5, 2021
Transcatheter mitral valve repair in a patient with prior atrial septal defect occlusion
Niikura H et al
free

Image – Interventional flashlight

10.4244/EIJ-D-23-00596 Nov 17, 2023
Electrosurgical laceration and stabilisation of three clip devices (ELASTA-Clip) to enable transcatheter mitral valve implantation
Curio J et al
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved